Search results | discovery

Reports

Discovery Stage Partnering Terms and Agreements in Pharma and Biotech

The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides a detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement.

Hearing Disorders Partnering

Hearing Disorders Partnering report provides understanding and access to the Hearing disorders partnering deals and agreements entered into by the worlds leading healthcare companies.

Idiopathic Pulmonary Fibrosis Partnering

The Idiopathic Pulmonary Fibrosis Partnering report provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies.

Smoking Cessation Partnering

Smoking Cessation Partnering report provides understanding and access to the smoking partnering deals and agreements entered into by the worlds leading healthcare companies.

Preventative Medicine Partnering

Preventative Medicine Partnering report provides understanding and access to the preventative medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

Drug Addiction Partnering

Drug Addiction Partnering report provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds leading healthcare companies.

Obesity Partnering

Obesity Partnering report provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies.

Retinopathy Partnering

Retinopathy Partnering report provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies.

Dry Eye Partnering

Dry Eye Partnering report provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds leading healthcare companies.

Conjunctivitis Partnering

Conjunctivitis Partnering report provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare companies.

Insights

Discovery stage in pharma and biotech partnering – Trends from 2009 to 2014

Numerous pharma and biotech partnering deals have been signed at the discovery stage over the past few years; discovery stage deals remain the most popular stage at which deals are announced.

Discovery, Preclinical and Clinical Stage – recent trends in pharma and biotech partnering 2009 to 2014

Discovery, preclinical and clinical stage pharma and biotech partnering forms a critical part of the drug candidate commercialization process.

Discovery stage partnering

Discovery stage partnering refers to a commercial deal or alliance signed when two…

AstraZeneca & Lead Discovery’s Pharma alliance

With a view to discover new medicines, for the treatment of human diseases with high unmet medical need, AstraZeneca has collaborated in a pharma alliance with Lead Discovery Center

Servier, a big pharma company in partnership with NovAliX for drug discovery research program

Servier, a big pharma company has inked a collaboration deal with NovAliX for small molecule drug discovery

Sanofi seeking pharma partners in India for cancer & diabetes drug discovery

The world’s fourth largest drug-maker, Sanofi, will tap Indian talent for its drug discovery in the field of oncology and diabetes and is looking for pharma partners to execute the same.

Xenon collaborates with Genentech for discovery of targeted pain therapeutics and diagnostics

Genentech and Xenon will collaborate in the development of novel targeted pain therapeutics as well in the development of associated companion diagnostics

Zydus Cadila plans to withdraw from drug discovery alliance with Eli Lilly

Indian pharmaceutical company, Zydus Cadila is planning to withdraw from its collaboration with Eli Lilly that involved joint drug discovery for cardiovascular diseases. 

BIO2010 Review: New approaches to early stage discovery dealmaking

A recent study claims it costs in execss of $1.3 billion to get from discovery to market!

New report: Global Autoimmune Disease Partnering 2010-2015

The Global Autoimmune Disease Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies

Events

Sorry, your search returned no results.


Deals

Sanofi and Evotec in drug discovery alliance

Evotec announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi

Sanofi and Adimab enter multi-target discovery pact

Adimab announced a multi-target discovery and optimization collaboration with Sanofi

Bayer and X-Chem in cardiovascular drug discovery program pact

X-Chem has licensed a second drug discovery program to Bayer Pharma pursuant to the multi-target collaboration the companies established in July 2012

Novartis and BioLineRx in drug discovery pact

BioLineRx has entered into a multi-year strategic collaboration agreement with Novartis Pharma designed to facilitate development and commercialization of Israeli-sourced drug candidates

Sanofi and Evotec in drug discovery pact

Evotec has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years

Merck and Euroscreen in drug discovery alliance

Euroscreen has entered into an exclusive world-wide research collaboration and licensing agreement with Merck & Co to discover and further develop compounds

C4X Discovery biopharma partners with Takeda for lead generation

C4X Discovery biopharma partners by signing a research collaboration agreement with Takeda Cambridge Limited.

BioFocus pharma alliances with Boehringer Ingelheim in drug discovery

BioFocus pharma alliances with big pharma Boehringer Ingelheim signing a new collaboration agreement

Genentech biotech deals Arrayit for drug discovery tool

Genentech has entered into biotech deals with Arrayit to purchase a drug discovery tool for $138,000.

Johnson & Johnson pharma deals for dengue fever drug discovery

Johnson & Johnson is joining the hunt for drugs to treat dengue fever – the world’s fastest-spreading tropical disease – by entering pharma deals with academic researchers in Belgium and the Wellcome Trust medical charity.